Position in GRAL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,773,214
+$1,370,353 QoQ
Shares Held
55,269
+18.9% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,233,577,400 across 30 Diagnostics & Research names. GRAL ranks #21 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
593,946 | $297,780,766 | |
| 2 | DHR |
Danaher Corp /De/
|
995,923 | $189,703,413 | |
| 3 | ILMN |
Illumina, Inc.
|
560,716 | $98,590,694 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
169,208 | $89,077,859 | |
| 5 | A |
Agilent Technologies, Inc.
|
500,807 | $66,522,193 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
332,138 | $64,175,704 | |
| 7 | WAT |
Waters Corp /De/
|
168,771 | $63,295,875 | |
| 8 | DGX |
Quest Diagnostics Inc
|
267,727 | $56,744,737 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,773,214 | 55,269 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,402,861 | 46,495 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,030,861 | 47,095 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,870,170 | 48,540 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,539,582 | 49,389 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $645,344 | 25,268 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $455,871 | 25,539 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $365,107 | 26,534 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $445,115 | 28,960 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||